Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma [Phase 2]
Phase II study evaluating isolated hepatic perfusion for ocular melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1) [Phase 1]
Phase 1 study evaluating MK-4827 in combination with temozolomide to assess safety and preliminary efficacy in adults with advanced cancers,…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Peptide Vaccination for Patients at High Risk for Recurrent Melanoma [Phase 2]
A Phase 2 trial evaluated a peptide vaccine for patients at high risk of recurrent melanoma. The study is completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma [Phase 2]
Phase 2 trial evaluating adjuvants accompanying peptide immunization in high-risk melanoma completed; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer [Phase 2]
Phase 2 trial testing gene-modified lymphocytes with high-dose aldesleukin and a cancer vaccine in progressive or recurrent metastatic kidne…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma [Phase 1, Phase 2]
A Phase 1/2 study evaluated the combination of bortezomib and temozolomide in adults with advanced refractory solid tumors or melanoma; the …
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients [NA]
A completed clinical trial evaluated the use of fibrin tissue adhesive in melanoma patients, sponsored by MD Anderson Cancer Center. The sni…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Taxotere/Temodar/Cisplatin Study in Melanoma Patients [Phase 1]
A Phase 1 trial evaluating the combination of Taxotere (docetaxel), Temodar (temozolomide), and cisplatin in patients with metastatic melano…
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: E7070 in Treating Patients With Stage IV Melanoma [Phase 2]
This clinical trial update concerns a Phase 2 study of E7070 in stage IV melanoma; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma [Phase 2]
Status update on a Phase 2 trial evaluating boron neutron capture therapy with boronophenylalanine-fructose complex in metastatic melanoma; …
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma [Phase 2]
Phase 2 trial update for ISIS 3521 in patients with advanced, unresectable, or metastatic non-small cell lung cancer or unresectable/metasta…
-
CLINICAL_TRIALS trial_result · 2012-07-10Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 1]
This document provides an update on a Phase 1 trial of a vaccine therapy in patients with stage IV melanoma.
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating a combination of chemotherapy, interferon alfa, and interleukin-2 in patients with metastatic melanoma has comple…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy [Phase 3]
A Phase 3 trial comparing CP-675,206 with dacarbazine or temozolomide in previously untreated melanoma patients has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: A Phase I/II Study of Dasatinib and Dacarbazine [Phase 1, Phase 2]
A Phase I/II study evaluating dasatinib in combination with dacarbazine for metastatic melanoma has completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluating a monoclonal antibody with or without gp100 peptides plus Montanide ISA-51 in stage IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 1]
A Phase 1 trial evaluated gene-modified autologous white blood cells followed by interleukin-2 and a cancer vaccine in metastatic melanoma; …
-
CLINICAL_TRIALS trial_result · 2012-06-15Clinical Trial Update: Of 18F MEL050 Using PET/CT in Metastatic Melanoma [EARLY_Phase 1]
Clinical trial update on the early-phase study of the PET radiotracer 18F MEL050 used with PET/CT in metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma [Phase 2]
Phase 2 trial evaluating a vaccine treatment combined with Interleukin-2 and treated lymphocytes for advanced melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial evaluating LMB-2 immunotoxin and vaccine therapy for patients with unresectable metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Haploidentical NK Cell Infusion in Malignant Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating haploidentical natural killer (NK) cell infusion for malignant melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma [Phase 1, Phase 2]
This clinical trial update reports the termination of a Phase 1/2 study of chemotherapy followed by infusion of DMF5 cells for metastatic me…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Study of CP-675,206 in Refractory Melanoma [Phase 2]
Phase 2 study of CP-675,206 in refractory melanoma has completed. The provided snippet does not include results or outcomes from the trial.
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma [Phase 2]
Phase 2 clinical trial update for a treatment of unresectable Stage III or metastatic Stage IV melanoma, sponsored by Astellas Pharma, with …
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody [Phase 1]
Phase 1 trial comparing two formulations of the CP-675,206 monoclonal antibody for melanoma has completed, sponsored by AstraZeneca.